Literature DB >> 7501855

Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation.

J S Meyer1, M P Harty, S Mahboubi, S Heyman, R A Zimmerman, R B Womer, J P Dormans, G J D'Angio.   

Abstract

Radiologic images and medical records of 42 children with Langerhans cell histiocytosis (LCH) (histiocytosis X) were reviewed to evaluate the presentation of the disease and the evolution of the radiologic findings. There were 26 male and 16 female patients aged 3 months to 18 years. Twenty-two patients presented with localized disease; 20 presented with multifocal disease. Four patients developed diabetes insipidus. Two patients had organ dysfunction. The radiologic findings were largely due to destructive bone lesions; 83% of the patients had at least one affected bone. Isolated soft-tissue masses, interstitial lung disease, and central nervous system abnormalities were also seen. Of patients in whom results of appropriate follow-up were available, 91% showed improvement in their lesions, 43% developed new lesions, and 92% had good clinical outcomes. LCH is usually a self-limited disease with a varied clinical and radiologic presentation. The prognosis is generally poor in children with organ dysfunction. In the absence of organ dysfunction, children with either localized or multifocal LCH have an excellent prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 7501855     DOI: 10.1148/radiographics.15.5.7501855

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  18 in total

1.  The variable presentation and natural history of Langerhans cell histiocytosis.

Authors:  J A Buckwalter; E Brandser; R A Robinson
Journal:  Iowa Orthop J       Date:  1999

Review 2.  Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement.

Authors:  E Michel Azouz; Gaurav Saigal; Maria M Rodriguez; Antonello Podda
Journal:  Pediatr Radiol       Date:  2004-07-28

Review 3.  Imaging of Histiocytosis in the Era of Genomic Medicine.

Authors:  Hyesun Park; Mizuki Nishino; Jason L Hornick; Eric D Jacobsen
Journal:  Radiographics       Date:  2018-11-30       Impact factor: 5.333

4.  Multisystemic Langerhans cell histiocytosis with advanced lung involvement.

Authors:  Ricardo Andrade Fernandes de Mello; Joana Waked Tanos; Melissa Bozzi Nonato Mello; Edson Marchiori
Journal:  J Radiol Case Rep       Date:  2012-11-01

Review 5.  Soft tissue Langerhans cell histiocytosis with secondary bone involvement in extremities: evolution of lesions in two patients.

Authors:  Behrang Amini; Rajendra Kumar; Wei-Lien Wang
Journal:  Skeletal Radiol       Date:  2013-04-23       Impact factor: 2.199

6.  Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy.

Authors:  Hyun Woo Goo; Dong Hyun Yang; Young Shin Ra; Joon Sup Song; Ho Joon Im; Jong Jin Seo; Thad Ghim; Hyung Nam Moon
Journal:  Pediatr Radiol       Date:  2006-07-29

7.  18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis.

Authors:  Julie Obert; Laetitia Vercellino; Axel Van Der Gucht; Constance de Margerie-Mellon; Emmanuelle Bugnet; Sylvie Chevret; Gwenaël Lorillon; Abdellatif Tazi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-20       Impact factor: 9.236

Review 8.  Imaging of painful scoliosis.

Authors:  Alun Davies; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

9.  Lacrimal gland and perioptic nerve lesions due to Langerhans cell histiocytosis (2007: 9b).

Authors:  M Herman; P Demaerel; G Wilms; S Van Gool; I Casteels
Journal:  Eur Radiol       Date:  2007-11-15       Impact factor: 5.315

Review 10.  Extra-osseous involvement of Langerhans' cell histiocytosis in children.

Authors:  Sabine Schmidt; Georg Eich; Sylviane Hanquinet; Heinz Tschäppeler; Peter Waibel; François Gudinchet
Journal:  Pediatr Radiol       Date:  2004-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.